Imunon, Inc. Accounts Payable
Imunon, Inc. (IMNN) had Accounts Payable of $3.52 million as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-03-28
- 2023-12-31: Accounts Payable, Current $3.52M.
- 2023-06-30: Accounts Payable, Current $2.61M.
- 2023-03-31: Accounts Payable, Current $3.97M.
- 2022-12-31: Accounts Payable, Current $3.59M.
| Period end | Accounts Payable, Current |
|---|---|
| 2023-12-31 | $3.52M 10-K · filed 2024-03-28 |
| 2023-06-30 | $2.61M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.97M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.59M 10-K · filed 2024-03-28 |
| 2022-09-30 | $3.37M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.39M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.47M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.55M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.62M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.11M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.10M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $2.24M 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.17M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.40M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $2.86M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.86M 10-K · filed 2021-03-19 |
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $3.39M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.59M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.02M 10-K · filed 2020-03-25 |
| 2018-09-30 | $3.16M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $3.70M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $3.42M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $3.42M 10-K · filed 2019-03-29 |
| 2017-09-30 | $2.81M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $3.54M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $4.05M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $2.88M 10-K · filed 2018-03-27 |
| 2016-09-30 | $3.03M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.95M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $2.76M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $2.83M 10-K · filed 2017-03-24 |
| 2015-09-30 | $2.50M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $3.20M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $4.11M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $3.48M 10-K · filed 2016-03-30 |
| 2014-09-30 | $4.44M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.62M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $2.10M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $1.45M 10-K · filed 2015-03-12 |
| 2013-09-30 | $2.25M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.52M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $4.18M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.34M 10-K · filed 2014-03-13 |
| 2012-09-30 | $2.94M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $4.31M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $3.71M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $4.01M 10-K · filed 2013-03-18 |
| 2011-09-30 | $2.77M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $3.33M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $4.55M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |